Pennsylvania HB1365 establishes a Medication-Induced Movement Disorders Screening Education Program.
Pennsylvania HB1365 creates the Medication-Induced Movement Disorders Screening Education Program within the Department of Health. This program aims to provide education and outreach on medication-induced movement disorders, which are neurological conditions caused by prolonged use of certain medications for mental health treatment. The program includes developing electronic informational materials, guidance for health care providers, and educational resources for the public. It also seeks to eliminate stigma for individuals affected by these disorders.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.